<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04990947</url>
  </required_header>
  <id_info>
    <org_study_id>2020-1594</org_study_id>
    <nct_id>NCT04990947</nct_id>
  </id_info>
  <brief_title>Direct Measurement of Food Intake Behaviour in Obese Women Before and After Bariatric Surgery or Lifestyle Intervention</brief_title>
  <acronym>CIBuS</acronym>
  <official_title>Direct Measurement of Food Intake Behaviour in Obese Women Before and After Bariatric Surgery or Lifestyle Intervention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rijnstate Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rijnstate Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess changes in food intake and food preference (e.g., fat and sugar) after bariatric&#xD;
      surgery and lifestyle intervention alone with a direct measurement.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 7, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in caloric intake</measure>
    <time_frame>Before RYGB / lifestyle compared to 4 weeks, 3 months, 6 months and 12 months after RYGB / lifestyle</time_frame>
    <description>kcal consumed</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Weight / BMI</measure>
    <time_frame>baseline, 4weeks, 3 months, 6 months, 12 months</time_frame>
    <description>weight and height measurements</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Drinking microstructure over time</measure>
    <time_frame>baseline, 4weeks, 3 months, 6 months, 12 months</time_frame>
    <description>Measured with the drinkometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in self-reported hunger, thirst, fullness, preference</measure>
    <time_frame>baseline, 4weeks, 3 months, 6 months, 12 months</time_frame>
    <description>VAS scale 0-100</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Bariatric Surgery Candidate</condition>
  <condition>Lifestyle</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Bariatric surgery (Roux-en-Y Gastric Bypass)</arm_group_label>
    <description>Patients who are eligible for RYGB</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lifestyle group</arm_group_label>
    <description>Patients with a BMI &gt; 30 who will start a lifestyle program</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>lifestyle / RYGB</intervention_name>
    <description>No intervention, just 2 different groups will be included</description>
    <arm_group_label>Bariatric surgery (Roux-en-Y Gastric Bypass)</arm_group_label>
    <arm_group_label>Lifestyle group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        RYGB or obesity with lifestyle intervention&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Woman&#xD;
&#xD;
          -  Age between 18 and 67 years of age (standard for eligibility for bariatric surgery)&#xD;
&#xD;
          -  Patients must be able to adhere to the study visit schedule&#xD;
&#xD;
          -  Independently mobile&#xD;
&#xD;
          -  Patients must be able to give informed consent (IC) prior to any study procedures&#xD;
&#xD;
          -  Surgical (1) and non-surgical (2) groups:&#xD;
&#xD;
               1. Eligible for bariatric surgery (BMI &gt; 35 kg/m2 and clinically indicated bariatric&#xD;
                  surgery operation in agreement with the IFSO criteria)&#xD;
&#xD;
               2. Patients with a BMI of 30-40 kg/m2, who are planning to join the COOL-lifestyle&#xD;
                  program&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pre-operatively/lifestyle group: Factors impairing ability to consume meal such as:&#xD;
             Significant dysphagia; Gastric outlet obstruction; Anything factor that prevents&#xD;
             subjects from drinking or eating a meal&#xD;
&#xD;
          -  Post-operatively: Factors impairing ability to consume meal such as: Significant and&#xD;
             persistent surgical complications or anything that prevents subjects from drinking or&#xD;
             eating a meal.&#xD;
&#xD;
          -  Systemic or gastrointestinal condition which may affect food intake or preference&#xD;
             (including diabetes mellitus)&#xD;
&#xD;
          -  Pregnancy or lactation, or planning to get pregnant during the study period&#xD;
&#xD;
          -  Patients who have an intolerance or allergy for one of the components of the test&#xD;
             product (e.g. lactose)&#xD;
&#xD;
          -  Active and significant psychiatric illness including substance misuse&#xD;
&#xD;
          -  Significant cognitive or communication issues&#xD;
&#xD;
          -  Medications with documented effect on food intake or food preference&#xD;
&#xD;
          -  Participating in another scientific study at the same time, if&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>67 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Yonta van der Burgh</name>
      <address>
        <city>Arnhem</city>
        <zip>6815 AD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yonta van der Burgh, MSc, MD</last_name>
      <phone>0880058888</phone>
      <email>Yvanderburgh@Rijnstate.nl</email>
    </contact>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>July 23, 2021</study_first_submitted>
  <study_first_submitted_qc>July 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 5, 2021</study_first_posted>
  <last_update_submitted>July 29, 2021</last_update_submitted>
  <last_update_submitted_qc>July 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

